Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy
Authors:
- 27 May 2022
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (10) , 4851-4865
Abstract
Background and Aims Optimal bowel preparation (BP) is critical for endoscopic assessment of inflammation and dysplasia in patients with inflammatory bowel disease (IBD). Comorbidities and patient-related factors have been associated with suboptimal BP (SOBP) in the general population. We sought to identify disease-specific characteristics that may impact the quality of BP in patients with IBD. Methods We conducted a retrospective analysis of adult IBD patients who underwent outpatient colonoscopies between January 2014 and September 2020 at a large academic medical center. Quality of BP was documented using the Boston Bowel Preparation Scale (BBPS) or the Aronchick scale and dichotomized into “suboptimal” (BBPS 0–5 or Aronchick “fair,” “poor,” unsatisfactory”) and “optimal” (BBPS 6–9 or Aronchick “excellent,” “good”). IBD-specific and other factors associated with SOBP were evaluated using logistic regression analyses. Results Among a total of 395 IBD patients [54% males, mean age 40 years, 63% with Crohn’s disease (CD), 35% with ulcerative colitis (UC)], 24.8% had SOBP. On multivariable analysis, moderate-to-severe endoscopic disease vs mild or inactive disease was associated with a higher odds of SOBP [adjusted OR 2.7(95% CI 1.52–4.94)], whereas baseline biologic use was associated with a lower odds of SOBP [aOR 0.24(0.09–0.65)] among the overall IBD cohort. Additionally, age > 65 years [aOR 2.99(1.19–7.54)] and single-dose vs split-dose BP [aOR 2.37(1.43–3.95)] were predictors of SOBP. In the subgroup analysis by IBD type, moderate-to-severe endoscopic disease predicted SOBP among both CD and UC cohorts. Conclusion Endoscopic disease activity was predictive of SOBP, and biologic therapy was protective against SOBP among IBD patients.Keywords
This publication has 40 references indexed in Scilit:
- Optimal bowel cleansing for colonoscopy: split the dose! A series of meta-analyses of controlled studiesGastrointestinal Endoscopy, 2014
- Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanlinessGastrointestinal Endoscopy, 2014
- Quality Bowel Preparation for Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease Is a MustGastrointestinal Endoscopy Clinics of North America, 2014
- Modified bowel preparation regimen for use in second‐generation colon capsule endoscopy in patients with ulcerative colitisDigestive Endoscopy, 2014
- Gastrointestinal motility disorders in inflammatory bowel diseasesWorld Journal of Gastroenterology, 2014
- Factors that Affect Adherence to Surveillance Colonoscopy in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Interplay between inflammation, immune system and neuronal pathways: Effect on gastrointestinal motilityWorld Journal of Gastroenterology, 2010
- Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulationBritish Journal of Clinical Pharmacology, 2005
- Impact of colonoscopy preparation quality on detection of suspected colonic neoplasiaGastrointestinal Endoscopy, 2003
- Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.Gut, 1994